International survey on the management of portal hypertension. [PDF]
Bashiri K +4 more
europepmc +1 more source
Sugar-Based Eutectic Systems Combined with Cyclodextrins for Enhanced Solubility of Carvedilol. [PDF]
Polo A +4 more
europepmc +1 more source
Editorial: Non-Selective Beta-Blockers in Decompensated Cirrhosis-More Friends Than Foes. [PDF]
Gagliardi R, Berzigotti A.
europepmc +1 more source
Prognostic Impact of Carvedilol vs. Metoprolol on Long-Term Outcomes in Patients with Heart Failure and Mildly Reduced Ejection Fraction. [PDF]
Weidner K +10 more
europepmc +1 more source
Feasibility and acceptability of pharmacist-led remote patient monitoring for carvedilol dose titration in clinically significant portal hypertension. [PDF]
Rodda S +7 more
europepmc +1 more source
Construction of α<sub>1A</sub>-Adrenoceptor-Based Stationary Phase Triggered by the Ultrahigh Affinity Protein Pair Colicin E7 Dnase /IM7 for Targeted Bioactive Compound Screening in Herba leonuri. [PDF]
Qiao X +5 more
europepmc +1 more source
Exploring Nonantibiotic Adjuncts: Synergistic Effects of Esmolol and Carvedilol With Tigecycline. [PDF]
Erinmez M, Koçer İ, Zer Y.
europepmc +1 more source
Therapeutic efficacy of combined esmolol and carvedilol treatment for myocardial ischemia in patients with coronary heart disease. [PDF]
Gao P +6 more
europepmc +1 more source
Carvedilol attenuates PTZ-induced epileptogenesis: associations with hippocampal neuroinflammation and PI3K/AKT/mTOR-related alterations. [PDF]
Madkour AH +3 more
europepmc +1 more source

